Catalyst Wire Dossier Catalyst Wire Dossier

Epoetin Hospira

epoetin alfa · Pfizer
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Epoetin Hospira, covering 2017-03-20 to 2018-07-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin [Phase 3]

See pricing